Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Institut national de la recherche scientifique

$34,000.00

Melatonin: functions and mechanisms of action in placental trophoblast

EF 2018-19

Résumé
Over the past nine years, our research program funded by NSERC-discovery grant has allowed demonstrating a crucial role of melatonin and its receptors in placental function. Melatonin is a heterogeneously-acting molecule with an exceptionally large skill set. Research within the last decade has shown melatonin to have previously-unsuspected beneficial actions on the peripheral reproductive organs, one of which very likely relates to its ability to obviate oxidative stress and placental dysfunction. We previously shown that melatonin is highly produced in the placenta where it protects against molecular damage and cellular dysfunction arising from oxidative stress. *This research proposal, which is a direct extension of our ongoing NSERC-supported program, builds on recent progress by identifying short-term goals with the long-term aim of understanding the role of melatonin at the maternal-fetal interface, the placenta, and to develop a cellular model to study the regulation and protective function of this indolamine. The short-term goals of the next 5 years is to elucidate the mechanisms by which melatonin protects the villous trophoblast against hypoxia/reoxygenation-induced damage. Specifically, in placental villous trophoblast cells, we will dissect the mechanism underlying melatonin protective on hypoxia/reoxygenation-induced mitochondrial (intrinsic) apoptosis and oxidative stress; and determine if melatonin regulates autophagy and protects against hypoxia/reoxygenation-induced endoplasmic reticulum-stress and mitochondrial dysfunction. Our program of research, using trophoblast cell, uses novel approaches to discover the mechanisms by which melatonin plays a pro-survival and cytoprotective role. At the same time there is no doubt that the proposed studies are particularly relevant for placental health and, by consequence for pregnancy well-being and fetal development. The findings of the proposed research will be of interest to a broad community, from the placentologist to the neurologist, pharmacologist and cellular biologist. Collectively, the proposed research program will advance our fundamental knowledge of the protective role of melatonin and its receptors in trophoblast cells as well as its role in normal and abnormal cellular processes (e.g. neurodevelopment, depression, cancer, and cardiovascular diseases) and open the way for the development of new preventive and therapeutic approaches in these areas. Melatonin has been suggested for the potential treatment of a variety of disorders, including obstetric complications, depression, cancer, and neurodegenerative disease.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2014-03948
Name nom
Vaillancourt, Cathy
Department département
Centre INRS- Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2014
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
5
Nb partie
5
Application title
Melatonin: functions and mechanisms of action in placental trophoblast
Keyword
NSERC
Application summary
Over the past nine years, our research program funded by NSERC-discovery grant has allowed demonstrating a crucial role of melatonin and its receptors in placental function. Melatonin is a heterogeneously-acting molecule with an exceptionally large skill set. Research within the last decade has shown melatonin to have previously-unsuspected beneficial actions on the peripheral reproductive organs, one of which very likely relates to its ability to obviate oxidative stress and placental dysfunction. We previously shown that melatonin is highly produced in the placenta where it protects against molecular damage and cellular dysfunction arising from oxidative stress. *This research proposal, which is a direct extension of our ongoing NSERC-supported program, builds on recent progress by identifying short-term goals with the long-term aim of understanding the role of melatonin at the maternal-fetal interface, the placenta, and to develop a cellular model to study the regulation and protective function of this indolamine. The short-term goals of the next 5 years is to elucidate the mechanisms by which melatonin protects the villous trophoblast against hypoxia/reoxygenation-induced damage. Specifically, in placental villous trophoblast cells, we will dissect the mechanism underlying melatonin protective on hypoxia/reoxygenation-induced mitochondrial (intrinsic) apoptosis and oxidative stress; and determine if melatonin regulates autophagy and protects against hypoxia/reoxygenation-induced endoplasmic reticulum-stress and mitochondrial dysfunction. Our program of research, using trophoblast cell, uses novel approaches to discover the mechanisms by which melatonin plays a pro-survival and cytoprotective role. At the same time there is no doubt that the proposed studies are particularly relevant for placental health and, by consequence for pregnancy well-being and fetal development. The findings of the proposed research will be of interest to a broad community, from the placentologist to the neurologist, pharmacologist and cellular biologist. Collectively, the proposed research program will advance our fundamental knowledge of the protective role of melatonin and its receptors in trophoblast cells as well as its role in normal and abnormal cellular processes (e.g. neurodevelopment, depression, cancer, and cardiovascular diseases) and open the way for the development of new preventive and therapeutic approaches in these areas. Melatonin has been suggested for the potential treatment of a variety of disorders, including obstetric complications, depression, cancer, and neurodegenerative disease.